These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37972270)

  • 61. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark.
    Johannesen CK; Rezahosseini O; Gybel-Brask M; Kristensen JH; Hasselbalch RB; Pries-Heje MM; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Jensen CAJ; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Dessau RB; Sørensen E; Harritshøj LH; Folke F; Sten C; Møller MEE; Engsig FN; Ullum H; Jørgensen CS; Ostrowski SR; Bundgaard H; Iversen KK; Fischer TK; Nielsen SD
    Microbiol Spectr; 2021 Oct; 9(2):e0090421. PubMed ID: 34668738
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.
    Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C
    JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Natural history of shedding and household transmission of severe acute respiratory syndrome coronavirus 2 using intensive high-resolution sampling.
    Altamirano J; Govindarajan P; Blomkalns AL; Leary S; Robinson I; Chun LX; Shaikh NJ; Robinson ML; Lopez M; Tam GK; Carrington YJ; De Araujo MB; Walter KS; Andrews JR; Burns J; Hogan C; Pinsky BA; Maldonado Y
    PLoS One; 2024; 19(7):e0305300. PubMed ID: 39052659
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
    Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
    Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
    Eyre DW; Taylor D; Purver M; Chapman D; Fowler T; Pouwels KB; Walker AS; Peto TEA
    N Engl J Med; 2022 Feb; 386(8):744-756. PubMed ID: 34986294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.
    Kociolek LK; Muller WJ; Yee R; Dien Bard J; Brown CA; Revell PA; Wardell H; Savage TJ; Jung S; Dominguez S; Parikh BA; Jerris RC; Kehl SC; Campigotto A; Bender JM; Zheng X; Muscat E; Linam M; Abuogi L; Smith C; Graff K; Hernandez-Leyva A; Williams D; Pollock NR
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33093026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
    O'Brien MP; Forleo-Neto E; Sarkar N; Isa F; Hou P; Chan KC; Musser BJ; Bar KJ; Barnabas RV; Barouch DH; Cohen MS; Hurt CB; Burwen DR; Marovich MA; Brown ER; Heirman I; Davis JD; Turner KC; Ramesh D; Mahmood A; Hooper AT; Hamilton JD; Kim Y; Purcell LA; Baum A; Kyratsous CA; Krainson J; Perez-Perez R; Mohseni R; Kowal B; DiCioccio AT; Geba GP; Stahl N; Lipsich L; Braunstein N; Herman G; Yancopoulos GD; Weinreich DM;
    JAMA; 2022 Feb; 327(5):432-441. PubMed ID: 35029629
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid diagnosis of SARS-CoV-2 pneumonia on lower respiratory tract specimens.
    De Pace V; Caligiuri P; Ricucci V; Nigro N; Galano B; Visconti V; Da Rin G; Bruzzone B
    BMC Infect Dis; 2021 Sep; 21(1):926. PubMed ID: 34493222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    Gottlieb RL; Nirula A; Chen P; Boscia J; Heller B; Morris J; Huhn G; Cardona J; Mocherla B; Stosor V; Shawa I; Kumar P; Adams AC; Van Naarden J; Custer KL; Durante M; Oakley G; Schade AE; Holzer TR; Ebert PJ; Higgs RE; Kallewaard NL; Sabo J; Patel DR; Klekotka P; Shen L; Skovronsky DM
    JAMA; 2021 Feb; 325(7):632-644. PubMed ID: 33475701
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modelling RT-qPCR cycle-threshold using digital PCR data for implementing SARS-CoV-2 viral load studies.
    Gentilini F; Turba ME; Taddei F; Gritti T; Fantini M; Dirani G; Sambri V
    PLoS One; 2021; 16(12):e0260884. PubMed ID: 34928966
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does sex modify the effect of pre-pandemic body mass index on the risk of Long COVID? Evidence from the longitudinal analysis of the Survey of Health, Ageing and Retirement in Europe.
    Wilk P; Stranges S; Cuschieri S
    Int J Obes (Lond); 2024 Jun; 48(6):821-829. PubMed ID: 38287094
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Karimzadeh S; Bhopal R; Nguyen Tien H
    Epidemiol Infect; 2021 Apr; 149():e96. PubMed ID: 33849679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.
    Chen PZ; Bobrovitz N; Premji ZA; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Aug; 10():. PubMed ID: 34414888
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of Seroconversion in Children and Adults With Mild COVID-19.
    Toh ZQ; Anderson J; Mazarakis N; Neeland M; Higgins RA; Rautenbacher K; Dohle K; Nguyen J; Overmars I; Donato C; Sarkar S; Clifford V; Daley A; Nicholson S; Mordant FL; Subbarao K; Burgner DP; Curtis N; Bines JE; McNab S; Steer AC; Mulholland K; Tosif S; Crawford NW; Pellicci DG; Do LAH; Licciardi PV
    JAMA Netw Open; 2022 Mar; 5(3):e221313. PubMed ID: 35262717
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs.
    Frediani JK; Parsons R; McLendon KB; Westbrook AL; Lam W; Martin G; Pollock NR
    Clin Infect Dis; 2024 Feb; 78(2):301-307. PubMed ID: 37768707
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a systematic review.
    Jefferson T; Spencer EA; Conly JM; Rosca EC; Maltoni S; Brassey J; Onakpoya IJ; Evans DH; Heneghan CJ; Plüddemann A
    J Hosp Infect; 2023 Feb; 132():62-72. PubMed ID: 36473552
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.
    Peart Akindele N; Kouo T; Karaba AH; Gordon O; Fenstermacher KZJ; Beaudry J; Rubens JH; Atik CC; Zhou W; Ji H; Tao X; Vaidya D; Mostafa H; Caturegli P; Blair PW; Sauer L; Cox AL; Persaud D
    J Infect Dis; 2021 Aug; 224(4):606-615. PubMed ID: 34398245
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.